pharma · Acute Myeloid Leukemia · Breast Cancer
First People's Hospital
The First People's Hospital of Lianyungang
First People's Hospital is a pharma organization headquartered in SAN DIEGO, CA, CN. Primary therapeutic focus areas include Acute Myeloid Leukemia, Breast Cancer, Gastric Cancer, Multiple Myeloma, Esophageal Squamous Ce
SAN DIEGO, CA, CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, CN
- Programs
- 1136
- Drugs
- 626
- Patents
- 123
cardonilizumab combined with renvastinib
Phase 2 · small molecule · Resectable Clear Cell Carcinoma of the Kidney
cardonilizumab combined with renvastinib for Resectable Clear Cell Carcinoma of the Kidney is a Phase 2 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Internal code 2024-HS-091
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- The First People's Hospital of Lianyungang
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Resectable Clear Cell Carcinoma of the Kidney
- Status
- active
- Trials
- 1